BRAINSTORM CELL THERAPEUTICS INC. 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Jun 23, 2016
Insider Transaction Report
Form 4
Friedman Mordechai
Director
Transactions
- Award
Stock Option (right to buy)
2016-06-22+16,666→ 16,666 totalExercise: $0.75From: 2016-07-22Exp: 2026-06-22→ Common Stock (16,666 underlying)
Footnotes (1)
- [F1]Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on July 22, 2016 until fully vested and exercisable on June 22, 2017, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.